Good morning,

Information regarding Influenza update COCA call below. Please note that if you are not able to make the call, it will be available for viewing later today.

Reminder: please encourage COVID-19 and Influenza vaccination where appropriate when patients present for testing or when making a diagnosis.

Thank you.

---------------

2021–2022 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Practitioners

Overview

Influenza remains a serious threat to children due to its potential to cause severe morbidity and mortality. The 2020–2021 influenza season was mild, but it’s not possible to predict how severe the upcoming season may be. Historically, low influenza virus circulation since March 2020, could result in a severe season for young children who may have lower immunity to influenza because they may not have been previously vaccinated or had natural exposure to influenza viruses.

Immunization remains the most effective way to prevent influenza illness, its complications, and death. Influenza immunization in the pediatric population is particularly important during the severe COVID-19 pandemic. Clinicians play a critical role in vaccinating children, their family members and caregivers, and themselves. Additionally, the early use of influenza antiviral medications in children can reduce the duration of symptoms and prevent severe complications of influenza.

During this COCA call, subject matter experts from the American Academy of Pediatrics (AAP) and CDC will discuss strategies primary care providers and medical subspecialists can use to improve, prevent, and control influenza among children this season.

If you are unable to attend the live COCA Call, the recording will be available for viewing on the COCA Call webpage a few hours after the live event ends.

The slide set will be available on the day of the call on the COCA Call webpage under Call Materials.

Free Continuing Education (CE) will be offered for this COCA Call.

Registration is not required.


Date: Thursday, October 7, 2021

Time: 2:00 PM – 3:00 PM ET

A few minutes before the webinar starts, please click on the Zoom link below to join: https://www.zoomgov.com/j/1601173046

Passcode: 214351

Or Telephone:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590

Or One-tap mobile:
US:
+16692545252,,1601173046#,,,,*214351# or +16468287666,,1601173046#,,,,*214351#

Webinar ID: 160 117 3046

International numbers available: https://www.zoomgov.com/u/aczUaOSnLX

Activity-specific Objectives

At the conclusion of the session, the participant will be able to accomplish the following—
1. Review data from the 2020-2021 U.S. influenza season to inform preparations for the 2021-2022 U.S. influenza season.
2. Highlight key recommendations in the AAP influenza policy statement, “Recommendations for Prevention and Control of Influenza in Children, 2021–2022” and in the CDC Advisory Committee on Immunization Practices’ document, “Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices—United States, 2021–22 Influenza Season.”
3. Discuss the importance of vaccinating, testing, and treating influenza during the COVID-19 pandemic.
4. Review recommendations about using influenza antiviral in children.


COCA Call Objectives


At the conclusion of the session, the participant will be able to accomplish the following—
1. Cite background information on the topic covered during the presentation.
2. Discuss CDC’s role in the topic covered during the presentation.
3. Describe the topic’s implications for clinicians.
4. Discuss concerns and/or issues related to preparedness for and/or response to urgent public health threats.
5. Promote health improvement, wellness, and disease prevention in cooperation with patients, communities, at-risk populations, and other members of an interprofessional team of healthcare providers.


Presenters


David Shay, MD
Medical Officer
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

Flor Munoz, MD, MSc, FAAP
Associate Professor of Pediatrics, Infectious Diseases, and Molecular Virology and Microbiology
Baylor College of Medicine


Instructions for Obtaining Continuing Education


To receive continuing education (CE) for WC2922-100721—Clinician Outreach and Communication Activity (COCA) Calls/Webinars—2021–2022 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Practitioners Thursday, October 7, 2021, please visit TCEO and follow these 9 Simple Steps by Monday, November 8, 2021.

To receive continuing education (CE) for WD2922-100721—Clinician Outreach and Communication Activity (COCA) Calls/Webinars—2021–2022 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Practitioners Thursday, October 7, 2021, (Web on Demand), please visit TCEO and follow these 9 Simple Steps between November 9, 2021 and November 9, 2023.



Accreditation Statement


CME: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.

The Centers for Disease Control and Prevention designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

CNE: The Centers for Disease Control and Prevention is accredited as a provider of Continuing Nursing Education by the American Nurses Credentialing Center’s Commission on Accreditation.

This activity provides 1.0 contact hour.

CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.

CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES) and/or Master Certified Health Education Specialists (MCHES) to receive up to total 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 0. CDC provider number 98614.

CPE: The Centers for Disease Control and Prevention is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is a designated event for pharmacists to receive) 0.1 CEUs in pharmacy education.

The Universal Activity Number is JA4008229-0000-21-230-L04-P and enduring JA4008229-0000-21-231-H04-P course category.

This activity has been designated as Knowledge-Based.

Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.

For Certified Public Health Professionals (CPH)
The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1.0 CPH recertification credit for this program.

AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.

DISCLOSURE: In compliance with continuing education requirements, CDC, our planners, our presenters, and their spouses/partners wish to disclose they have no financial interests or other relationships with the manufacturers of commercial products, suppliers of commercial services, or commercial supporters, except Flor Munoz would like to disclose that she receives a royalty for authoring the Seasonal Influenza in Children chapter in UpToDate and is a member of the Data Safety Monitoring Board (DSMB) – Pfizer, Moderna and a member of the American Academy of Pediatrics (AAP) Committee on Infectious Diseases (COID).

Planners have reviewed content to ensure there is no bias.

The presentation will not include any discussion of the unlabeled use of a product or a product under investigational use.

CDC did not accept commercial support for this continuing education activity.

The Emergency Risk Communication Branch in the Division of Emergency Operations, Center for Preparedness and Response is responsible for the management of all COCA products.

For information about this update or other clinical issues, or to send your feedback, please contact us at coca@cdc.gov
• CDC Clinician Outreach and Communication Activity Facebook page—connect with COCA on Facebook
• Clinician Outreach and Communication Activity—resources for healthcare providers
• COCA RSS Feed—subscribe to be notified of conference calls, updates, and CDC guidance for health providers
• Crisis & Emergency Risk Communication Training—training program that draws from lessons learned during public health emergencies, and incorporates best practices from the fields of risk and crisis communication
• Health Alert Network—CDC's primary method of sharing cleared information about urgent public health incidents with public information officers; federal, state, territorial, and local public health practitioners; clinicians; and public health laboratories


Centers for Disease Control and Prevention
1600 Clifton Rd Atlanta, GA 30329 1-800-CDC-INFO (800-232-4636) TTY: 888-232-6348
Questions or Problems | Unsubscribe







Snohomish Health District
3020 Rucker Ave., Everett, Washington
Unsubscribe